Page 1

SEPTEMBER 2018

Inorganic • Atomic Absorption • ICP-OES Spectrometers • ICP-Mass Spectrometers • Sample Digestion System

www.expresspharmaonline.com

Chromatography • Gas Chromatographs • Customized GC Analyzers • Liquid Chromatographs • Headspace & Thermal Desorbers

Molecular & Vibrational Spectroscopy • UV-Vis, UV-Vis-NIR • FTIR, FTNIR • IR/NIR Microscopy & Imaging • Fluorescence Spectrometers

Thermal & Elemental analysis • DSC • TGA • STA (DTA) • DMA • CHNS/O & N2 Analyzers

Hyphenated techniques • TG-IR • TG-MS • TG-GC/MS • TGA-IR-GCMS • UV-DSC/DMA

®

NexION 1000 & 2000 ICP-MS

Flexar™ Series HPLC & UHPLC

To get USP Guideline Posters PerkinElmer (lndia) Pvt. Ltd. th G-Corp Tech Park, 8 Floor, Near Hypercity Mall, Ghodbunder Road Kasarvadavali, Thane (West) – 400 615, Maharashtra, India. CIN No.: U74999MH2004PTC145744 www.perkinelmer.com

Scan here

®

Copyright ©2018, PerkinElmer, Inc. All rights reserved. PerkinElmer is a registered trademark of PerkinElmer, Inc. All other trademarks are the property of their respective owners.

Mass Spectrometry • GCMS • LC/MS/MS • Portable GCMS


Solutions from Research to Process

for Pharmaceutical Applications Demanding research needs all the support it can get. Cole-Parmer can support your complete discovery needs, scalable to production. • Trusted for over 60 years for bioprocessing and pharmaceutical solutions • Products designed to deliver uniform performance for high quality results, meeting regulatory requirements • Get the choice with the features you need from one source • Exceptional service along with technical and validation support

Peristaltic Pumps

Cleanroom consumables

Safety Products

Chromatography

Test & Measurement

Cell Culture

Electrochemistry

Lab Essentials

Need demo/samples? Contact us at:

022-6139-4444 / response@coleparmer.in

See product range at:

ColeParmer.in


EDITOR’S NOTE Chairman of the Board Viveck Goenka Sr. Vice President-BPD Neil Viegas Asst. Vice President-BPD Harit Mohanty Editor Viveka Roychowdhury* BUREAUS Mumbai Usha Sharma, Raelene Kambli, Lakshmipriya Nair, Sanjiv Das, Swati Rana, Tanuvi Joe New Delhi Prathiba Raju DESIGN Asst. Art Director Pravin Temble Chief Designer Prasad Tate Senior Designer Rekha Bisht Graphics Designer Gauri Deorukhkar Senior Artist Rakesh Sharma Digital Team Viraj Mehta (Head of Internet ) Photo Editor Sandeep Patil Marketing Team Rajesh Bhatkal Ambuj Kumar Debnarayan Dutta Ajanta Sengupta E Mujahid Nirav Mistry PRODUCTION General Manager BR Tipnis Manager Bhadresh Valia

Celebrating the success story that is Sikkim

S

ikkim, a fertile land of great beauty, has always attracted tourists. Its mountain peaks, glaciers, lakes, hot springs and mountain passes have been its claim to fame but this sparsely populated, third-smallest state after Goa and Delhi, has been slowing transforming itself into a hub for India's pharmaceutical sector over the last decade. The stimulus for this transformation has been the North East Industrial Policy (NEIP), 1997 which was further revised into the new North East Industrial & Investment Promotion Policy (NEIIPP) 2007. The Union Finance Ministry has further clarified that existing pharma units undertaking ‘substantial expansion’ between December 1, 2014 to March 31, 2017 (the date when NEIIPP expires) will continue to enjoy excise duty exemption for a period of ten years, i.e. till March 2027. In addition, new units registered during the same period would be also eligible for the excise exemption. This is the main reason that over 25 pharma companies, including Cipla, Sun Pharma, ZydusCadila, Alembic, IPCA, Alkem Lab, Intas Pharma, Torrent Pharma, Micro Labs and Unichem, flocked to this state over the last few years. Many companies have migrated from older pharma hubs to Sikkim, the new kid on the block. Besides the tax concessions, a vital component of this change has been educational institutions like the Sikkim Manipal University (SMU), a partnership between the Government of Sikkim and the Manipal University, which has provided a talent pipeline of professionals thanks to its technical, healthcare and science education streams. This local talent pipeline lowers the cost of skilled manpower, which combined with low manufacturing costs add up to an attractive package. But what will it take for Sikkim to sustain its success story? The very mountains which attract tourists add to the topographical challenges of transporting raw materials into Sikkim and transporting finished goods out of the state. So also, have pharma companies finally been able to attract senior management to base themselves and their families here at the plant sites? Express Pharma’s inaugural Sikkim Pharma Summit is the first step to spotlight these and many challenges as well as success stories of pioneering senior management within the pharma fraternity as well as pharma companies which took a chance on Sikkim and invested in the state. Personnel who made Sikkim home over the last decade are witnesses to the many changes over the last few years. Under the theme, ‘Building India Advantage: Enhancing efficiencies, Maximising Value,’ experts and veterans of the industry will gather at the Sikkim Pharma Summit to analyse Sikkim’s journey as a pharma hub in the last few years, how challenges were met and solutions found. We also hope to understand the lessons learnt and therefore conclude the best way forward. Do join us in this journey to celebrate the success that is Sikkim!

VIVEKA ROYCHOWDHURY Editor viveka.r@expressindia.com

Scheduling & Coordination Santosh Lokare CIRCULATION Circulation Team Mohan Varadkar

4

SIKKIM PHARMA SUMMIT SPECIAL

September 2018

EXPRESS PHARMA


ROUNDTABLE

ADVANTAGE SIKKIM Sikkim has emerged as a major pharma hub and has attracted many pharma companies in the last one decade. Industry stakeholders share their views on how the mountain state is contributing to their growth story.

UMESH MISHRA, SR VICE PRESIDENT OPERATIONS- SIKKIM, INTAS PHARMACEUTICALS

T

he pharmaceutical industry started its operations in Sikkim in 2007. Apart from incentives offered under the NEIIPP, 2017, the pharma industry could flourish in the state of Sikkim because of local convenience and benefits available, such as: Industry friendly atmosphere, good natured people, a pro-industrial government with a visionary leader, clean environment, availability of local talent, and peace and harmony in the state. The atmosphere out here in Sikkim is friendly in comparison to other states. Be it individual or any company, everybody is welcomed here

with open arms. As a result it becomes very easy for any new industry to start and establish itself. People of Sikkim are extremely warm hearted and good natured. This makes the entry and operation of any industrial unit convenient as nothing can succeed without the support of local citizen. The government of Sikkim led by Pawan Chamling, Chief Minister, Sikkim, has been extremely cooperative and instrumental from the very beginning in creating an atmosphere conducive for the development of the pharma industry. Here the government machinery, system and departments have

always worked hand in hand to support the pharma industry. Pharma industry has been able to flourish in the

state of Sikkim due to good governance provided under the visionary leadership of Pawan Chamling. Here the environment is pollution free and ideal for establishments and sustenance of the pharma industry. Local educated youth are available in plenty who could be made industry fit, after necessary skill development by the industry. In Sikkim, a general sense of safety and security prevails, which is an essential requirement for development of any industry. Although, geographically Sikkim is remotely located with scarce transportation, still it can be considered as a haven for the pharma indus-

try in true sense.

About the company Intas is a global pharmaceutical formulation development, manufacturing and marketing company headquartered in India. Intas’ success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, biotechnology and global operations over three decades. It also has a presence in cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management as well as other therapeutic segments.

VINOD KUMAR NIGAM, PLANT HEAD- SIKKIM, INDCHEMIE HEALTH SPECIALITIES

O

ur plant is located near Rangpo river and surrounded with mountains and beautiful greenery natural scenic view. The surrounding is pollution free atmosphere in short we can say in the womb of nature. In august 2007 we started the production of Sikkim unit-I Indchemie health Specialities. Sikkim government provided us full support to smooth operation of plant with interest of local people. Initially we are having solid doses form that is tablet and capsules and in second plant we started our oral liquid oint-

6

ment also. As initial days local people were unaware about pharma manufacturing activity. We trained them as per our area wise requirement with on job training. Our MD M K Singh Sir, always remind us that our employees are our assets. We have to care about them. In 2008 we got first WHO GMP accreditation without any non-compliance. Here we are getting benefits through North East Industrial and Investment Promotion Policy (NEIIP). The benefit is for 10 years tenure. The subsidy on Capital investment is 30 per

SIKKIM PHARMA SUMMIT SPECIAL

September 2018

cent on total investment on plant and machinery. Transport subsidy we are availing from Siliguri to Sikkim at Rs. 3.78 per Kilogram. Income Tax for employer is 100 per cent benefited. We also get interest subsidy on bank loan and insurance subsidy 100 per cent refundable on premium. Excise duty previously was 58 per cent and now in GST 29 per cent is exempted. Now we are exporting to some ROW market , Cambodia, Sri lanka, Nepal and Vietnam.

About: Indchemie Health Specialities

has been in the ethical pharma business for more than two decades now, with leadership in few of the segments. It has a strong back up of in-house manufacturing facility and has four pharmaceuticals manufacturing units (two at Daman, third at Baddi, Himachal Pradesh & fourth at Sikkim) in India. The company's comprehensive range of products covers wide therapeutic segments wherein a large number of products are technologically backed up with bioequivalence studies at par with brand leaders in the segment.

EXPRESS PHARMA


ROUNDTABLE NITYANAND JHA, GM-PRODUCTION- SIKKIM, ALKEM across 35 countries globally. The company has over 1000 employees worldwide, with

three manufacturing sites across India and four international divisions with offices in In-

High-speed diverters

dia, Europe, Hong Kong and the US. Alchem International is an export-orientated company with

Track design flexibility

sales in over 35 countries. 90 per cent of the production is exported out of India.

Purely magnetic holding

S

ikkim is a beautiful mountainous clean and green organic state. Being a peaceful state enriched with adequate hydro-energy power it facilitates the promotion of many industries. Pharma industries are major attraction among them. Being a pollution free environment, there are so many reasons that is contributing to the company’s growth. Income tax benefit, GST benefit/refund and subsidies in capital goods, insurance and transport are the major benefits provided by the Sikkim government, which acts as a major contributors. Man-power and energy costs are less compared to other location and are easily available. All central and state government related bodies are supportive to make the licensing/approval process easier. The transportation of finished goods is easier as products can be distributed easily in all high consuming states. Also, the export process is easier for neighbouring country like Nepal and can meet the demand within a shorter span of time. So in the current scenario, Sikkim is a major pharma hub for our country.

Ultimate Production effectiveness www.br-automation.com/ACOPOStrak

office.in@br-automation.com | +91-20-41478999

ROI

OEE TTM

About the company Founded in 1935, Alchem International is a pioneer in the field of phytochemicals with over 75 years of experience in providing plant derived active ingredients to the pharmaceutical, cosmetic and nutraceutical industries

SIKKIM PHARMA SUMMIT SPECIAL

ACOPOStrak

7

September 2018

Enabling the adaptive machine. Like no other transport system.


ROUNDTABLE DR UPENDRA S QUENIM, PLANT HEAD (OPERATIONS AND QUALITY)- SIKKIM, SWISS GARNIER GENEXIAA SCIENCES

O

ur Sikkim plant was the brain child of our MD, MS Theivendran and Finance Director T Rethinavalli. They decided to tread onto a mountain terrain unknown to us. When we set up our unit here, Sikkim impressed us as a land, conducive for industry. It is not only about the tax haven. Sheer warmth of the people, no red-tapism, good governance of the state government, increasing focus on ecosystem, education, infrastructure convinced us that our MD's vision was simply on the dot.

8

Today, the Sikkim plant contributes to 30 per cent of our turnover, provides direct employment to nearly 400 people and business opportunities to hundreds more. Our management believes in compliance to the law of the land. We recognise the fact that good manufacturing practices should be a habit complimented by good infrastructure. Our plant is equipped with the state of art machines and utilities purchased from brand leaders. Our employees are our strength and we take good care of them. This is in keeping with the vision of

SIKKIM PHARMA SUMMIT SPECIAL

September 2018

try's top companies. This gives us an opportunity to imbibe the contemporary practices in the pharmaceutical firmament. The State government works with industry closely and we endeavour to have a clean and green Sikkim.

About the company

our top brass. We manufacture for the pharmaceutical indus-

Swiss Garnier is a global pharmaceutical manufacturer specialising in development and production of innovative pharmaceutical formulations. Incorporated in 2006 as a contract manufacturing company, today the company has a turnover of

over ` 350 crores and has four manufacturing facilities catering to both domestic and international markets. The company's mission is committed to customer satisfaction, employee empowerment and environmental care. The company is determined to become a global healthcare provider in areas of pharmaceuticals, nutraceuticals, alternative system of medicines and hospital services duly providing consistent quality and timely delivery to the utmost satisfaction of all the associates and customers.

EXPRESS PHARMA


ROUNDTABLE DEEPAK KUMAR VERMA, PROJECT HEAD- SIKKIM, ZUVENTUS HEALTHCARE

Z

uventus Healthcare’s Sikkim plant is a stateof-art manufacturing facility with oral solid dosage (OSD) forms, including ferrous. The facility has a separate block of B-Lactum OSD form, which is one of the best facilities in the country. Location wise, the plant is situated at one of the most beautiful locations and also has the faciities in Sikkim. It is believed that this

facility will be utilised to fulfil the own requirements first, and then plans will be carried out on how to utilise the facility to its full capacity. There have been many enquiries related to the production of Beta-Lactum products, by many companies in the country, related to the Beta-Lactum facility. The production in the facility started in February 2017, and by now validation

batches of the internal product range is almost over. Zuventus team believes that this state-of-art facility has created a different image of the organisation and is confident it will help attain growth.

About the company Zuventus Healthcare, founded in 2002 is a joint venture of Emcure and has emerged as a leader in acute and semi chronic ther-

apies in the Indian pharma market. The company also provides cancer care products, and pain management and wound care therapeutics. It has a strong manufacturing capabilities and their products pass through stringent tests backed by following quality systems that ensure compliance with international standards.

compile by Swati Rana, swati.rana@expressindia.com

We from Optima Pharma are convinced: A demanding customer should never have to settle for mediocre solutions and - above all - not when it comes to safety and hygiene. This is why we plan, develop and design filling lines that keep all the options open – regardless where your machine will produce.

p-mec India | November 28–30, 2017 | Mumbai | India Hall 6 | Booth # F 34 We will present pharmaceutical turnkey projects in 3D.

OPTIMA pharma GmbH 74523 Schwaebisch Hall | Germany | www.optima-packaging.com/pharma OPTIMA India Packaging Machines Pvt. Ltd. Unit 110, 1st Floor, Brigade Rubix | Plot No. 20, HMT Main Road Bangalore - 560 013 | India | +91 80 46525900 | www.optima-packaging.in

EXPRESS PHARMA

SIKKIM PHARMA SUMMIT SPECIAL

9

September 2018


Note: Express Pharma, a leading industry publication, has been tracking Sikkim’s potential to become as a pharma hub. Below is the reprint of an article covered in its August 16-31, 2016 issue

Sikkim THE POTENTIAL PHARMA HUB

Thanks to the North-East Industrial and Investment Promotion Policy (NEIIPP) 2007, Sikkim has been able to offer a host of tax benefits to the industry. Thus it is no wonder that the state has already attracted an investment of over $400 million from 22 major pharma companies in the last three years. At this pace, the state could emerge as a major pharma hub in the North Eastern region by 2018 By Prathiba Raju

10

SIKKIM PHARMA SUMMIT SPECIAL

September 2018

EXPRESS PHARMA


S

ikkim, a pristine hilly state renowned tourist destination, could turn also out to be the next pharma hub in the country. Situated amidst the verdant Eastern Himalayas, the state has already attracted an investment of over $400 million (`2000 crores) from 22 major pharma companies in the last three years. Marquee companies like Cipla, Sun Pharma, Zydus Cadila, Alembic, IPCA, Alkem Lab, Intas Pharma, Torrent Pharmaceuticals and Unichem have reportedly set up their units in the state.

Sikkim - the new pharma buzz Many pharma companies and their ancillary units have migrated from Baddi in Himachal Pradesh and Uttarakhand to Sikkim, as the excise duty exemption given to these states will soon expire. In order to avail tax benefits for the next ten years, several pharma companies have opted to migrate to Sikkim. Besides tax incentives, low manufacturing and labour costs and a pollution-free environment have also proved to be the key attractions for these pharma companies. “Twenty years ago, Baddi was just a dusty town. There was no industry and a dearth of opportunities for locals. The tax holiday announced in 2003 transformed Baddi into Asia's largest pharma hub which eventually became one of the biggest industrial centres in North India. But with the tax holiday likely to end, the scenario is changing. Now, pharma companies have made a beeline to Sikkim to avail the excise benefits,” informs J Jayaseelan, Chairman of the Tamil Nadu chapter of Indian Drugs Manufacturers Association (IDMA). Sikkim, which offers 100 per cent excise and income tax benefits in addition to freight subsidy, provides continuous support to set up new plants with other facilities. By 2018, the state will become a full-fledged pharma hub in the North Eastern region, predict industry experts. A senior official from Commerce and Industries Department, Government of Sikkim, while speaking to Express Pharma, on condition of anonymity said, “Today, Sikkim is home to as many as 22 pharma companies, out of which 16 are big firms, one is medium and five are small scale firms. These include the who’s who of the Indian pharma sector such as Cipla, Sun, Zydus Cadila, Alembic, IPCA, Alkem, Intas, Torrent,

EXPRESS PHARMA

Unichem and Micro Labs.” According to the official, North-East Industrial and Investment Promotion Policy (NEIIPP) 2007 has played an active role to attract pharma investments in the state. “Many pharma companies have set up shop because of the big tax advantages as earning is at a faster pace due to tax savings. Apart from pharma companies, ancillary units like packaging, access to raw materials, components, machinery, have also set up their base. We are now working to make the state more conducive for pharma units, so that it can become a major pharma destination in the next two years,” the official stated. Giving an industry view point, Suresh Pareek, Managing Director, Ideal Cures, a company manufacturing and exporting pharma excipients and ready-to-use coating systems, said, “Logistically, Guwahati is the most ideal location for pharma companies, but due to insurgency issues, it did not develop. Though Sikkim has issues of air and rail connectivity, the state offers a conducive work environment. Currently, 30 pharma plants have their presence in the state. A few have started their facilities, while others are yet to be operational.” Ideal Cures is also currently setting up a large facility, which is likely to be operational by January 2017.

Role of NEIIPP The steady increase of pharma investments in Sikkim is easy to understand if one considers the policies at play. In 2007, the Government of India had approved a package of fiscal incentives and other concessions for the North East Region, namely the North East Industrial and Investment Promotion Policy (NEIIPP), which was a boon for pharma companies and ancillary units in the region. The Centre, however, suspended NEIIPP in December 2014 and it will expire by March 2017. Suspension of NEIIPP will be a major hurdle for the North Eastern states, particularly for the pharma industry, as many big companies have invested and are in the process of further investing in the state. However, the Union Finance Ministry, in its notification, said that existing units undertaking ‘substantial expansion’ between December 1, 2014 to March 31, 2017 (the date when NEIIPP expires) will continue enjoying excise duty exemption for a period of ten years, it also mentioned that new units

SIKKIM PHARMA SUMMIT SPECIAL

11

September 2018


registered during the same period would be also eligible for the excise exemption. Under NEIIPP, which came into force from April 1, 2007, with a validity of ten years, industrial units in the North East region are eligible for 30 per cent capital investment subsidy, income tax subsidy, excise duty exemption (varying from goods to goods), and reimbursement of insurance premium paid on capital assets, among others. Industrial units can enjoy these benefits for a period of ten years. A notification from the Union Finance Ministry states, “Doubts have been raised regarding the availability or otherwise of central excise duty exemption under notification No.20/2007 dated 25.04.2007 to new units or units undertaking substantial expansion after 1.12.2014 in the North Eastern region including Sikkim pursuant to the suspension of fresh registrations under NEIIPP. The matter has been examined by the Ministry of Finance in consultation with Department of Industrial Policy and Promotion (DIPP). It clarified that new units or units undertaking substantial expansion shall continue to be eligible for excise duty exemption.”

12

The tax holiday announced in 2003 transformed Baddi into Asia's largest pharma hub which eventually became one of the biggest industrial centres in north India. But with the tax holiday likely to end, the scenario is changing. Now, pharma companies have made a beeline to Sikkim to avail of the excise benefits J Jayaseelan Chairman,Tamil Nadu Chapter, IDMA

Logistically, Guwahati is the most ideal location for pharma companies, but due to insurgency issues, but it did not develop. Though Sikkim has issues of air and rail connectivity, it has a conducive work environment Suresh Pareek Managing Director, Ideal Cures

“Although the Centre’s notification has brought clarity among the industries, NEIIPP should be restored for ease of trade in the North Eastern region,” informs RS Joshi, Chairman, Federation of

SIKKIM PHARMA SUMMIT SPECIAL

September 2018

Industry and Commerce of North Eastern Region (FINER), the premier trade and industry body of the North East. “Any industrial unit, which will start its operation on or within March 2017, will get

tax exemptions. If big pharma companies can start production before March 2017, they will be eligible for tax benefits for the next ten years i.e. till March 2027. But, since there is less time available for new units

to come up, so we have asked for extension of time. The government is yet to give any clear signal,” says Joshi. Joshi further says, “Suspension of NEIIPP is a matter of great concern as the policy was helpful to attract investment for 'Make in North-East' and its continuation is a must to make 'Make in India' initiative successful. Suspension of NEIIPP will badly affect all North Eastern states.” “Sikkim has benefitted by the NEIIPP policy 2007. With a large industry base of pharma and ancillary units, the state has been able to provide more employment and create new jobs. Ultimately, the state government is reaping the benefits. If NEIIPP is suspended, industrial development will come to a halt,” cautions Pareek. Thus, many experts are of the opinion that the government should rethink its decision to discontinue with NEIIPP. They also recommend implementing more effective financial mechanisms, introducing industry-friendly polices and an increased focus on infrastructure development to sustain and propel Sikkim’s growth as a pharma hub. prathiba.raju@expressindia.com

EXPRESS PHARMA


BUSINESS AVENUES

EXPRESS PHARMA

SIKKIM PHARMA SUMMIT SPECIAL

September 2018

13


BUSINESS AVENUES

14

September 2018

SIKKIM PHARMA SUMMIT SPECIAL

EXPRESS PHARMA


BUSINESS AVENUES

SIKKIM PHARMA SUMMIT SPECIAL

KILITCH HEALTHCARE INDIA LTD. Avoid the

Harmful Side Effects of Preservatives

India’s first ever Preservative Free Ophthalmic Manufacturing Facility Widely accepted by Ophthalmologist

Patented Pure Flow Technology For contract manufacturing contact: Kilitch Healthcare India Ltd. 902/B Godrej Colesium, Behind Everad Nagar, Near Priyadarshani Cirlce, Sion (East), Mumbai – 400022. Tel. : 022 6137 2222 Mr. Divya Mehta : +91 9819724957 www.kilitchhealthcare.com info@kilitchhealthcare.com

EXPRESS PHARMA

September 2018

15


BUSINESS AVENUES

SIKKIM PHARMA SUMMIT SPECIAL

OSMOMETER 3250

Milk Cryoscopes Available

127, Bussa Udyog Bhavan, Tokershi Jivraj Road,Sewri, Mumbai - 400015. India

Tel: +91-22-24166630 Fax: +91-22-2662776 E-mail: support@rosalina.in Web: www.rosalina.in

16

September 2018

EXPRESS PHARMA


BUSINESS AVENUES

EXPRESS PHARMA

SIKKIM PHARMA SUMMIT SPECIAL

September 2018

17


BUSINESS AVENUES

18

September 2018

SIKKIM PHARMA SUMMIT SPECIAL

EXPRESS PHARMA


PRODUCTS

Self adhesive strip plays a crucial part in sealing

S

elf-adhesive strip plays a crucial part in sealing and spacing throughout a multitude of different industrial sectors. Strips that are manufactured from EPDM make ideal seals against any ingress of water or air. Self-adhesive strip has a closed cell structure and therefore don’t allow any liquid, gases or air to pass through them, creating a perfect airtight seal on your products. The compression of the EPDM base material allows for uneven surfaces to be securely sealed once clamped down onto. EPDM has excellent

plain expanded EPDM and a good conduct adhesive. EPDM provide excellent resistance against oil, acid, alkalis and has good weathering against heat and ozone.

resistance to UV and ozone and therefore is widely used in external applications when parts will be subject to weathering. EPDM is a relatively cheap sponge material choice making it a cost effec-

tive solution to most sealing application.

Advantage of Epdm Self Adhesive Strip Easy to install, just peel off the

self-adhesive backing. The adhesive backing tape used is not fully resistance to water, therefore where there is a large amount of moisture or water present; it is advisable to use

Ami Polymer 319, Mahesh Industrial Estate, Opp. Silver Park, Mira-Bhayander Road, Mira Road (E), Thane - 401104, Maharashtra Tel.: +91 22 28555 107 / 631 / 914 | Cell: +91 86910 13935 Email: mktg@amipolymer.com | Web: www.amipolymer.com

Gandhi Automations’clean room high speed doors a necessity

B

etter quality or better yield is the primary reason for investing in a cleanroom space. It goes straight to the bottom line. Numerous manufacturing facilities now require a controlled environment in which one can limit the amount of dust and dirt in the area of the manufacturing. Medical instrument manufacturing and packaging, electronics and computer manufacturing, food preparation and some military applications are but a few of the instances that have strict requirements for maintaining a clean environment. One needs to know the requirement for specific product or process. Clean rooms have become integral part of pharma manufacturing facilities. One of the most important aspects of cleanrooms is the doors which needs to be chosen for cleanroom facility. Time for which door is open will play a critical factor in

EXPRESS PHARMA

avoiding dust, outside temperature, humidity etc. Opening and closure of door has to be quick enough to isolate the outside environment and internal facility. Gandhi Automations provide clean room high speed doors specifically designed for above purpose. The clean room high speed doors are best suited for facilities when there is a requirement of controlled environment. The opening and closing of door is

quick enough to separate outside environment and internal facility. High speed clean room doors designed by Gandhi automation are engineered carefully with feature below:◗ Concept of low air permeability in pressurised rooms with positive and negative air pressure ◗ Designed to fit inside the

columns ◗ Self-supporting construction ◗ Minimises air leakage ◗ Can be equipped with transparent PVC horizontal sections or vision windows ◗ Special side guides to tightly integrate the curtain ◗ High leak tightness due to the close filling curtain in the guide rails ◗ High door efficiency with and low permeability values, EN 12426 EN 12427: < 12

m3/m2 h Δ 50 PA . ◗ Control device enclosure in Stainless Steel SS 316 Contact details Gandhi Automations Chawda Commercial Centre Link Road, Malad (W) Mumbai – 400064, Off: +91 22 66720200 / 66720300(200 Lines) Fax: +91 22 66720201 Email: sales@geapl.co.in Website : www.geapl.co.in

SIKKIM PHARMA SUMMIT SPECIAL

19

September 2018


COMPANY PROFILE

SCIEX: Meeting the evolving needs of the laboratory

S

CIEX is a leader in life science and analytical technologies, pioneering solutions in mass spectrometry paired with capillary electrophoresis and liquid chromatography. Its world-class service and support has made it a trusted partner to scientists and lab analysts worldwide, focussing on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis.

SCIEX in pharma and biopharma ◗ Transforming biologics pipeline capacity and capability SCIEX has a longstanding

SCIEX offers innovative technology that makes complex workflows easier and more efficient, while delivering the utmost in data quality

track record in helping scientists in pharma discovery, development and manufacturing to transform pipeline capacity and capability through the adoption of CE and LC-MS technologies. ◗ Increase productivity and make critical decisions faster Sciex’s overall aim is to make their customer more productive and in doing so saving time, money and resources. That’s why their approach workflows with complete endto-end solutions. Their unparalleled application knowledge works hand-in-hand with bestin-class hardware, software

20 SIKKIM PHARMA SUMMIT SPECIAL September 2018

and support, engineered and integrated to make you more productive and successful. SCIEX offers innovative technology that makes complex workflows easier and more efficient, while delivering the utmost in data quality. Highly reliable instrumentation, with high sensitivity and dynamic range for a variety of analytical applications. Advanced software with automation to make data processing easier. SCIEX mass spectrometers are at the forefront of quantitative and qualitative analyses and deliver the speed and sen-

sitivity that ensures best results. Their Triple Quadrupole Linear Ion Traps, the QTRAP mass spectrometers are based on proven, accurate quantitation capabilities of SCIEX Triple Quad systems, but with enhanced scan functions to enable simultaneous quantitation and confirmation. Additional MS scans, only attainable using the SCIEX QTRAP system, can deliver new and exciting discoveries for identification, characterisation and quantitation of the customer’s samples. From high-throughput analysis to detailed analyte investiga-

tions, the QTRAP system gives them the ability to both quantify and find unknowns in their sample, without any sacrifice to sensitivity. The X500 QTOF series are the first accurate mass systems that can deliver true qualitative and quantitative results in a single injection. These revolutionary benchtop high resolution accurate mass spec instruments have been designed exclusively to boost productivity in high-throughput sample analysis laboratories. The X-series QTOF MS Systems are powered by the SCIEX OS user interface for simplified easeof-use and streamlined data acquisition and analysis – it has never been easier to screen for unknown compounds, metabolomic analysis or performing biotherapeutic characterisation. Now one can future proof their laboratory with a system that is robust enough for high-throughput workflows, and powerful enough for research and discovery!

EXPRESS PHARMA


COMPANY PROFILE

ACG Films & Foils: Partnering progress I

n the world of packaging, ACG is indisputably a recognised player offering its services to several industries across the world. ACG takes pride in being an award-winning manufacturer of a range of high-quality barrier packaging films for the pharma, medical-device, healthcare, and food packaging sectors. It understands the critical role of packaging in pharma industry and consistently strive to provide reliable and innovative solutions to its customers, building a symbiotic relationship of needs and offerings. ACG’s diverse portfolio of packaging solutions includes pharma-grade and camera-inspected range of aluminium-based films and foils (Alumlid, Alumpack, CSR/SF foils, and tropical foils), specialty packaging films (Alukbliss, Suppose, Unidose), high barrier packaging films (Aclar and Ultrasafe), anticounterfeiting solutions (Brandshield) and multilayer PVC films (Tripac, Dupac, Ecopac). ACG offers pharmagrade barrier packaging films that are manufactured right from PVC resin stage to calendering and slitting stage, which not only guarantees consistent quality but also ensures traceability of every batch supplied. Their world-class manufacturing facilities cater to the pharma and allied industries across the world.

ACG’S flagship aluminium-based packaging solutions 1. Alumpack: Cold form blister foils Alumpack is a premium grade cold form base foil made from validated raw material sources that are compliant with global regulatory standards. The foil serves as an ultra-high barrier packaging solution which improve product protection and increased shelf life.

ACG advantages ◗ Excellent barrier against moisture, oxygen, light and gases ◗ Exceptional formability and sealability with common lidding materials ◗ High delamination resistance with use of primer ◗ Customised colours and printing options 2. Alumlid: Aluminium lidding foils Alumlid is a premiumgrade lidding foil material for thermo-form and cold-form blister packs. The foil is made from validated raw material sources that are compliant to the global regulatory standards and exhibits exceptional seal-ability to common blister materials made of PVC, PVdC, PE and PP. The foil serves as an ultra-high barrier packaging solution, assuring utmost product protection and an enhanced shelf life.

Numerous certifications and advanced equipment gives an edge over competitors ◗ Distinguished with almost every certification needed for global pharma packaging markets ◗ US FDA, European Pharmacopoeia and CFDA regulation compliant ◗ Complies with cGMP norms along with coating, lamination, printing and slitting facilities

EXPRESS PHARMA

ACG advantages under Class 100,000 ◗ Equipped with high-speed multilayer laminator for aluminium foils and polymerbased packaging films ACG believes that innovation is the way to progress and ACG’s Innovation lab stands

testimony to this belief. The lab is led by highly accomplished and expert professionals from the packaging industry to keep pace with market dynamics to fulfil customer's needs. Through collaboration with customers, the innovation

lab offers intuitive solutions adding value to their products. The innovation lab has successfully launched specialty films like Alukbliss and Brandshield, which have garnered several global accolades for innovation.

◗ Internationally accepted structures and gauges ◗ Exceptional barrier against moisture, oxygen, light and gases ◗ Excellent sealability ◗ Multiple opening options including peel, peel-push,

SIKKIM PHARMA SUMMIT SPECIAL

21

September 2018


COMPANY PROFILE push-through and tear-open 3. CR/SF Foils: Lidding foils for child-resistant and senior-friendly blisters ACG’s child-resistant/senior-friendly lidding foils provide highest safety by preventing children from easy opening of the blister and high-level convenience and user friendliness for adults. The applications include peelable, peelpush and push-through options that prove the highest level of functionality. All the foils provide high degree of protection against moisture, oxygen and light.

ACG advantages ◗ Wide range of structures as per international standards ◗ Unique child-resistant lidding mechanism ◗ Exceptional lidding mechanism with apt functionality for

senior citizens ◗ High degree of protection of individual dose 4. Tropical Foils: Aluminium-based laminates for tropical blister applications ACG’s tropical blister foils provide enhanced protection to the thermoformed blisters that not only adds to the aes-

thetics of the packaging but also provides an impermeable barrier to sensitive products against moisture, oxygen and light. Tropical foils can ideally be used to pack all kinds of medicines for an extended shelf life.

ACG advantages ◗ High barrier against mois-

ture, oxygen, light and gases ◗ Compact size blisters in comparison with cold form blisters ◗ Superior aesthetics ACG understands the critical role of packaging in pharma industry and consistently strives to provide reliable and innovative solutions to its customers, building a symbiotic relationship of needs

Propix: Enabling technical excellence P

ropix manufactures fast and accurate, vision based inspection solutions to help the industry match the desired quality standards while maintaining the pace of the packaging process. With rapid industrial growth and increasing speeds in packaging lines, vision inspection systems are considered to be of utmost importance in the crucial stage of production called quality control. The vision of the company is to attain technical excellence by identifying 'unthought-of' solutions that delights its customers and its mission is to provide unparalleled solutions and state-ofthe-art technology, with emphasis on quality control and production continuity, in

22

keeping with the increasing demands of production and current validation standards. Propix specialises in innovation-based, vision inspection systems for diverse industrial applications across pharma, food and beverage, FMCG and printing industries. Since its inception in 2004, the company has grown to prominence, delivering well-designed camera based inspection systems and related services to customers across India. The turnkey vision inspection systems meet manufacturer quality assurance requirements across multiple market segments and product packaging types. These easyto-use camera based inspection systems can accurately inspect products at high speeds, protecting the manu-

SIKKIM PHARMA SUMMIT SPECIAL

September 2018

facturer's brand image without reducing throughput. Propix concentrates on devising effective and efficient technology solutions that inspect and weed out errors at all crucial stages of production as well as packaging. It invests heavily in R&D to ensure that products and services aid its customers in producing end products that surpass industry standards. The objective is to attain the apex position in the customers' minds whenever they think of vision inspection solutions. The company takes pride in its ability to provide customised solutions to serve the complex needs of the various industries that it caters to. Propix believes in creating long-lasting business relationships through continual sup-

port and correspondence, beyond installation and sales. It values customers' time, appreciate their specific requirements and respect deadlines. The team of technocrats comprises software engineers, design engineers, support engineers and production specialists who pride themselves in providing ingenious, automated inspection solutions to cater to the specific needs of clients across various industries. This team, of highly qualified and skilled professionals, possesses the domain knowledge and the experience to understand the vision inspection needs of various industries. It possesses the capability to deliver customised, camera-based inspection solutions to every industry that Propix caters to.

and offerings through its products and value-added services.

ACG’s value-added services ◗ Assistance in pack characterisation ◗ Regulatory support ◗ Technical services ◗ Customisation of packaging films and foils

The company's state-ofthe-art research facility and in-house mechanical tool room enable the veteran brain power to continually develop the technically sound and advanced vision inspection solutions to offer their clients across various industries. Propix believes in creating long-lasting business relationships through continual support and correspondence. Hence, its team also comprises dedicated sales and marketing staff, who provide time-critical support, beyond installation and sales. Its extensive network covers every corner of the country, helping Propix serve its clients better. It utilises the company's strong global presence to bring clients the best industry solutions and practices.

EXPRESS PHARMA


COMPANY PROFILE

Domino: Coding solutions of quality D

OMINO is one of the world’s largest manufacturers of Coding & Marking, digital printing solutions. Its products are used for date coding, product marking, serialisation and variable printing onto products used in everyday life. Its customers are some of the most recognisable brands in healthcare, food, beverage and commercial printing. Domino Printech India is a fully owned subsidiary of Domino Printing Sciences.c. Cambridge, UK. Domino was the first ink jet coding company to come to India in 1988. Domino India is a leading supplier of coding solutions in the country. Its primary and secondary coding technologies find application in large and key areas of industry segments which include: Food, Pharma & Healthcare, Dairy, Beverages, Paints &

Chemicals, Cosmetics & Personal Care, Engineering, Breweries & Distilleries and a host of other industries. Products produced by the company include Continuous

tion systems and Digital Colour Label Presses. Software products produced by the company include Inkjet and Production line Controllers and Coding Automa-

messaging, from product to pallet, right from the factory floor. Fully scalable to suit your production line, one can manage data simply with a touch screen PC interface and create accurate

Inkjet (Small Character) systems, Piezo Micro Drop on Demand (Piezo DOD) systems, Scribing Laser Coding and Marking systems, High Speed Binary Inkjets, Valve Jet Drop on Demand (Large Character) systems, Print And Apply Label Applicator Systems (PALM), Thermal Inkjet (TIJ) systems, Thermal Transfer - packaging printing systems Fume Extrac-

tion software. Domino is an expert to fulfill serialisation and aggregation needs. They have products and industry expertise which can fulfill their customer’s needs and render their position as a global leader.

labels from Domino’s built-in product table. Industry standards of product identification and coding are always evolving. This is a good thing for the health, safety and security of customers – but it can prove a challenge for suppliers. Domino understands that their customers need high quality, accurate product marking solutions which meet

QuickDesign Stay fully compliant and in complete control of your package

this challenge, while also integrating with the existing production processes. The serialization and coding of products is an essential part of the production process. It ensures compliance with the latest legislation and, ultimately, safeguards the health of users. But it can also prove challenging to implement – particularly when dealing with difficult to mark materials. They bring global expertise, in-depth domain knowledge and vast local industry experience to successfully cater to wide ranging coding needs across various industry segments. They offer reliable products, innovative solutions and dependable services at the best possible value to their customers. Domino India has a pan-India presence to support their customers.

Shree Naina Glass: Innovating packaging S

hree Naina is a strong and consistently growing private limited enterprise. It is a 15 year old company with strong business ethics, technical expertise and a fundamentally innovative company in the plastics packaging business. All its facilities are ISO certified and all its production and packaging is done under a clean room environment. The company is a large integrated supplier with the latest machines and state-of-the-art facilities which are capable of high production and large economies of scale. It stocks variety of preforms, bottles and wide mouth jars in different shapes and sizes, ranging from 9 ml to 08 litres with different weight

EXPRESS PHARMA

categories, in a 30,000 sqm warehouse. With experience and knowledge the company provides strong technical assistance to its customers. Shree Naina, over a short period of time, has become a top of the line manufacturer specialising in high quality pet bottles, pet preform, wide mouth jars and injection molded articles. The company's integrity has kept the team devoted to honouring its commitment towards customer satisfaction that exceeds the expectations of those it serves. Constantly striving towards innovation, the company sets challenging goals and has been achieving them year after year, constantly committed towards excellence and pursuing the

highest standards in creating value for its customers. The company's vision is to provide solutions with passion and excellence and its mission is to enhance customer delight through assured quality, excellent products and value for money. Visual inspection and quality checks are conducted on the entire production. The company ensures stringent quality parameters to ensure performance and durability. With the ever evolving market needs, a stringent quality control becomes the backbone of an efficient business. Shree Naina constantly invests resources in maintaining the highest quality standards and processes. To further ensure proper dimensional control

and to produce quality goods the company uses premium grade virgin raw materials. With continual commitment to total quality management, Shree Naina continues to evolve its expertise in delivering leading edge packaging solution in the market. As a long term sustainable quality process, the company has established and maintained a fully equipped quality control laboratory to carry out dimensional checks with proper calibrated measuring instruments like fully automatic top load tester, wall thickness tester to ensure final product should remain as per standard. With its top focus towards creating a better and environmentally responsible value for

the customers, Shree Naina is poised for upward growth as an international competitive manufacturer buoyed by international marketing networks, vast production base, technical expertise and consistency in high quality using the latest technologies. Shree Naina's continuous emphasis on consistent high quality has helped shape its suite of quick yet precise quality check systems which have enhanced the production speed without compromising the quality. The company's approach of adopting cutting edge technologies and processes to provide innovative packaging solutions has resulted in Shree Naina evolving as a company with an `1800 million turnover as of 2014.

SIKKIM PHARMA SUMMIT SPECIAL

23

September 2018


COMPANY PROFILE

Ami Polymer: Strength and durability E stablished in the year 1996 at Mumbai, Ami Polymer is devoted towards manufacturing and supplying the finest quality range of silicon rubber products, mechanical seals, silicon tubes and hoses, silicon gaskets, rubber cords, rubber O-rings, etc. These products are widely demanded for their high strength, precise design and durable finish standard. The offered product range is manufactured in compliance with the set industry standards using quality assured rubber material, silicon material and modern techniques under the strict supervision of its experts. The provided products are exam-

ined against various quality parameters to deliver a flawless supply at the clientsâ&#x20AC;&#x2122; end. Moreover, the entire product range is also available in various specifications as per the demands of esteemed clients. The company offers all of its products under the brand name Ami Polymer. By delivering clients the best quality products, the company has been able to meet its requirements in an excellent manner. The experienced team of professionals manufactures these products in adherence to the set industry standards and norms. In addition to this, Ami Polymer's quality experts rigorously test these products against various quality parameters by making use of modern

testing tools and devices. Being a client-centric firm, the company has been able to attain the maximum satisfaction of its esteemed clients. Moreover, its easy payment modes, transparent dealings, client-centric approach and reasonable price structure have placed the organisation at the top of the industry. Under the leadership of the Director, the company has been able to meet the bulk and urgent requirements of its valuable clients in the best possible way. Backed by a large manufacturing unit that sprawls over a wide area of land, the entire unit is well-facilitated with advanced machines and equipment in order to manufacture

the best quality products for the company's valuable clients. This unit is operated by a skilled team of adept professionals that enables Ami Polymer to meet the specific requirements of the clients within a promised time-frame. Moreover, in order to enhance production capacity, the company regularly upgrades its manufacturing unit as per the latest developments and technology. The company is one of the largest manufacturers and exporters of platinum cured silicone tubings, reinforced hoses and inflatable seals gaskets for Food-Pharma-Biotech Industries. There are nine different extrusion lines with

online laser inspection device to achieve accurate dimensional properties in silicone extrusions. All extrusion lines are well equipped and with latest manufacturing technology. The company has a strength of 175 employees and 3500+ clients in domestic as well as overseas market. APPL also manufactures and exports customised moulded and extruded products in silicone, viton and EPDM elastomers. Some of its exports markets are Germany, Mexico, Malaysia, Spain, Italy, Portugal, Saudi Arabia, etc. The company's specialities include fast delivery, strong technical support, competitive prices and trusted quality products.

Svam Packaging: Blending ideas & technology Svam has S taken utmost vam Packaging industries, a 30-year-old organisation aims to serve the packaging requirements of the growing Indian pharma industry. Svam is prepared to cater to the international market with its quality products and services. The company's continuous research and development programmes has allowed Svam to become the first and the largest producers of pharma flexibles, especially cold form laminates in India. The team of R&D is continuously monitoring and developing new features within existing packaging to ensure anti-counterfeiting features as well as ensuring development of new cost effective laminates to ensure finest packaging for the pharma industry. To gain new heights and enhance the scope of supplies, anti-counterfeits and technologies, SVAM is open for joint ventures and

partnerships with its vendors, customers and other associates which brings value to the market. From coding to printing or blister packing machines to blister packing materials, the team is equipped with strong technical know how of the product and deep product knowledge. The technologists are trained by the OEMâ&#x20AC;&#x2122;s of the blister packaging machine to serve its customers. Best of ideas and a blend of advanced technology drives the company to become one of the top notch pharma packaging companies in the market. Svam believes that in pharma, the value of the product is the life of someone, and due to this belief the team has taken utmost care and protection to ensure one of the finest grade of packaging materials for pharma. A dedicated team

24 SIKKIM PHARMA SUMMIT SPECIAL September 2018

care and protection to ensure one of the finest grade of packaging materials for pharma and infrastructure regularly monitors the quality for each and every batch of raw materials, semi-finished or finished materials. The production or processing machines are equipped with special features from Germany, Switzerland and USA to ensure consistency in

the quality of lamination and ensuring no compromise in the quality of the laminate. The quality control lab comprises all the latest machines for testing the laminates and even a blister packing machine with different shapes of tools/cavities for regular testing the performance of laminates produced by the company. Each and every batch produced by the company is tested on this blister machine. Svam are the first producers of cold form laminates in India producing one of the finest quality of the same. The company's non stop research and development are focussed in a direction to offer anti-counterfeiting solutions as well as cost effective packaging solutions to the pharma industry. Its experts are well trained on the blister packaging machines as well as consumables, which

gives Svam an edge over others to offer its clients with a complete detailed study about their packaging requirements. Focusing on pharma, the company's state-of-the-art facility comprises lamination, printing, coating and slitting machines with advanced features and major equipment that are imported from specialised manufacturers of the equipment, enabling Svam to produce consistent quality of the product and maintain a clean atmosphere inside the plant. The quality lab comprises nearly all the necessary equipments required for testing of each and every raw material as well as finished products. It also has a blister packaging machine with different change parts/ cavities design made for different forming ratios to test formability of its laminate as well as testing delamination.

EXPRESS PHARMA


COMPANY PROFILE

Cole-Parmer: Preferred partner to scientific and engineering communitysince 2006 in India W

ith over 60 years in the industry, ColeParmer is a leading manufacturer and supplier of fluid handling, environmental testing, electrochemistry, general laboratory equipment and consumable supplies. The company’s close association with the pharmaceutical industry has enabled them to develop products and solutions to meet industry’s stringent requirements for testing and manufacturing. Their application knowledge and expertise combined with in-depth understanding of customers’ needs enables them to provide integrated solutions that address their customer’s requirements. Cole-Parmer today is seen as a substantial, superior value, one-stop package of innovative products, quality service and technical support. Cole-Parmer has established a strong presence in the last 12 years in the Indian pharma and biotech markets. For biopharma product development, ColeParmer is proficient in providing custom solutions and scale-up assistance from R&D to pilot and to manufacturing. Carrying on the strong foundation, the company aims at continuous growth and therefore is meticulously investing in enhancing its product portfolio. It has added many renowned brands in the last three years to strengthen it’s Pharma portfolio – Techne, Jenway, Stuart, Electrothermal, Argos Technologies, Kinesis, Vaplock, Traceable, and Ismatec to name a few. Cole-Parmer offers complete solution from research to process applications. Whether it’s a lab set-up or scale-up, the company has wide range of products and services to offer. In the bioprocess re-

EXPRESS PHARMA

search and manufacturing space, Cole-Parmer is the most trusted choice for their Masterflex Peristaltic Pumps and fully validated pharma tubing. Other key application areas, in which end-to-end customised solutions are most looked for are aseptic fluid transfer, including a wide range of single-use products such as bioprocess bags and liners, manifolds, and EZ Top container closures. The company has also very rapidly expanded its offerings in safety and cleanroom consumables. Cole-Parmer is amongst very few companies who manufacture pharma latex gloves, specifically made for pharma applications addressing related stringent regulatory concerns. The company today has an extensive range of latex and nitrile gloves for various pharma applications like research, cleanroom, oncology, chemical handling, and delicate object handling etc., provided with complete validation support including factory audit, making it a reliable choice for the customers.

Cleanroom range also includes apparels, microfiber wipers, goggles, chairs, shoes, and cleanroom supplies like mats, paper, mops, rollers, and swabs etc, meeting requirements of cleanroom environment. Range of plasticware and labware is also added to the consumables portfolio, for customers to get complete solution for their cell culture and research applications. Another recent addition to the portfolio is chromatography end-to-end solutions, which includes HPLC and GC columns, protein separation columns, fittings, Vaplock solvent delivery and waste systems, SGE micro syringes, D2 & HC lamps and vast range of AccuStandard standards. The company is also known for vast range of lab equipment and essentials, which include stirrers and mixers, baths and circulators, melting point apparatus, spectrophotometers, reaction stations, cell culture solutions, temperature products, and data loggers, to name a few. In addition to Cole-Parmer's portfolio of proprietary and industry-leading brands, the company is renowned for offering exceptional service and technical support. Customers rely on the company’s team of trained and experienced application experts for help in selecting the right product for their application, troubleshooting existing equipment, and solving regulatory compliance issues. It all adds up to a promise that Cole-Parmer as ‘Scientific Experts’ works to fulfil every day: delivering solutions customers trust and therefore is considered as preferred partner for end-to-end solution to the scientific community.

SIKKIM PHARMA SUMMIT SPECIAL

25

September 2018


COMPANY PROFILE

Datwyler: Delivering cutting-edge solutions D

atwyler is a focussed industrial supplier with leading positions in global and regional market segments. With a total of more than 50 operating companies, sales in over 100 countries and some 7,500 employees, the company generates annual revenue of some CHF 1,300 million. The growth strategy has strong roots. The history of the Datwyler group shows that there are a few typical values that lead to success for a family business. These are entrepreneurship, customer focus, excellence and respect for others. Datwyler established these values as official corporate values and presented them to its employees at its 100th anniversary. Over the period of 100 years, Datwyler has evolved from a family-owned Swiss company

into an international group. Building on its strong roots, the company has developed its own style with high standards and unique values. Datwyler strives to deliver sustainable profitable growth for the benefit of its stakeholders as the foundation for adding longterm value and preserving the corporate independence of the Datwyler Group. In its efforts, the company is addressing the challenges of its times. The independent sustainability report is according to the guidelines of the Global Reporting Initiative (GRI). This has been checked and confirmed by GRI. The Datwyler Group also reports its greenhouse gas emissions to CDP (formerly Carbon Disclosure Project). Datwyler is currently building a new plant in the US for the

production of high-quality healthcare components. With this plant and state-of-the-art digital manufacturing technologies, the company is laying the foundation to better serve the rapidly growing demand from US healthcare companies. The First Line manufacturing concept incorporates ultra-modern clean room technology, automated production cells, fully automated camera inspection and a unique washing process. It therefore meets the highest requirements for cutting-edge delivery systems for injectable drugs. Because of the strategic planning process, Datwyler distributor Distrelec is now concentrating more on maintenance, automation and robotics. These niche markets are particularly attractive due to the exist-

ing skills within Distrelec, the current competitive situation and the predicted growth. In order to provide added value to target customers, Distrelec is adjusting its value proposition, optimising its webshops, employing technical specialists, pushes its own brand RND and optimises its product range. This strategy of catering specifically to the needs of target customers is already yielding encouraging results. With the accelerated international expansion of Reichelt, Datwyler is also supporting profitable growth in the technical components division. Datwyler wants to be proactive in exploiting new possibilities and opportunities associated with digitalisation and turn these into a competitive advantage. For this purpose, it is investing some CHF 50 million

over the next few years. In doing so, it is looking to increase the efficiency of business processes, improve data quality, increase IT security and create a strong and flexible platform for future digital applications. This will also allow future acquisitions to be integrated more quickly and easily. Also, the introduction of the web-based success factors solution will help the company to reduce complexity in the organisation, increase the efficiency of cooperation and encourage employees to identify with the company. Interaction between employees and the company is becoming ever more digital and agile. To give an example SuccessFactors will assist Datwyler to get better and faster at recognising its required training needs and to increase awareness of trainings that already exist.

Beckman Coulter: Focussed on innovation A dvancing research and discovery is our foundation, built on an 80-year legacy of innovation. At Beckman Coulter, we are dedicated to advancing and optimising the laboratory. For more than 80 years, we have been a trusted partner for laboratory professionals, helping to advance scientific research and patient care. We have a vital role: our focus on innovation, reliability and efficiency has led us to become the partner of choice for clinical, research and industrial customers around the globe. In the life sciences, researchers use Beckman Coulterâ&#x20AC;&#x2122;s precision instruments to study complex biological problems, including causes of

disease and potential new treatments. Our team of experts dedicates the time and energy to understand the complexity of research for laboratory customers in a wide variety of settings: universities, government, biotechnology and pharmaceutical companies, hospitals, and commercial laboratories. By innovating new processes and technologies, weâ&#x20AC;&#x2122;re challenging conventional wisdom; our goal is to develop the best, most widely trusted laboratory solutions available on the market today. Spotlight on todayâ&#x20AC;&#x2122;s discussion shall be online analysis of pharma waters, facility monitoring and particle characterisation in

26 SIKKIM PHARMA SUMMIT SPECIAL September 2018

formulations. Manufacturers of injectable products are required by local and international regulators to ensure that the water that they use in their manufacturing process meets certain quality attributes. TOC analysers play a vi-

tal role in ensuring the quality of purified water and water for injection used in the pharma and biopharma manufacturing process meets the required national and international regulatory standards. By attending this seminar, you will learn how Anatel online

TOC analysers can help you improve compliance, get better data integrity and reduce your operating costs whilst assuring your water quality. During the seminar, you will learn where and why TOC analysers are used in water systems, what the regulatory requirements are, how TOC analysers work, and how the Anatel PAT700 can reduce your operating costs while increasing your compliance and data integrity. Anyone working in biopharma or pharma manufacturing processes, using WFI or PW will benefit from attending. Additionally there will be the opportunity to interact and discuss your requirements with Beckman Coulter experts.

EXPRESS PHARMA


Profile for Indian Express

Sikkim Pharma Summit Special - September 2018  

Express Pharma, a leading industry publication, has been tracking Sikkim’s potential to become as a pharma hub.

Sikkim Pharma Summit Special - September 2018  

Express Pharma, a leading industry publication, has been tracking Sikkim’s potential to become as a pharma hub.

Advertisement